GENE POLYMORPHISM IN ASSOCIATION WITH ATHEROSCLEROSIS DEVELOPMENT AND COGNITION DISORDERS IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE
https://doi.org/10.15829/1728-8800-2015-1-30-34
Abstract
Aim. To study the interrelation of polymorphic gene variants playing role in atherosclerosis development, with cognition disorders, central nervous system condition and chronic heart failure (CHF) course specifics in patients with ischemic heart disease. Material and methods. 40 patients with CHF I-IV functional class (NYHA) of ischemic origin underwent cognition testing, nuclear-magnetic resonance tomography of the brain, duplex brachiocephalic arteries scanning, gene APOC3, ABCA1 и PON1 polymorphism assessment, and lipid, homocystein, brain natriuretic peptide measurement (BNP). Results. The interrelations of polymorphic gene variants APOC3, ABCA1 и PON1 were found with morphological changes in the brain and cognition tests results. T allele at PON1 (polymorphism L55M A>T) and allele A at PON1 (polymorphism Q192R A>G) associated with the worsening of Burdone correction test, and T allele of APOC3 gene (polymorphism -482C>T) was linked to the decrease of diffusion coefficients in gray as in white matters. There are statistically significant relations of the polymorphisms studied with the levels of plasma lipids, homocysteine and carotid arteries diameter and intima-media complex thickness. While studying relations of polymorphic genes ABCA1 и APOC3 variants (C3238G) and CHF duration, BNP level and end- systolic size of the left atrium it was found that the allele A of gene ABCA1 and allele G of gene APOC3 ^3238G) are associated with longer duration of CHF. The increase of the left atrium size and higher BNP levels were shown in patients — carriers of C allele gene APOC3 (polymorphism -428 C>T).
Conclusion. There is interrelation of gene polymorphism that are associated with lipid metabolism disorders, CHF course and cognition functioning and morphological changes in central nervous system in CHD patients.About the Authors
T. V. MartynovichRussian Federation
N. S. Akimova
Russian Federation
E. A. Fedotov
Russian Federation
Yu. G. Shvarts
Russian Federation
References
1. Shvarc JG, Akimova NS, Martynovich TV. Analysis of changes in white matter of brain and cognitive disturbances in patients with chronic heart failure and ischemic hear t disease. Saratov scientific medical Journal 2013; 9(1): 78-82. Russian (Шварц Ю. Г., Акимова Н. С., Мартынович Т. В. Анализ изменений белого вещества головного мозга и когнитивных расстройств у пациентов с хронической сердечной недостаточностью и ишемической болезнью сердца. Саратовский научно-медицинский ж 2013; 9(1): 78-82).
2. Heckman GA, Patterson ChJ, Demers C, et al. Heart failure and cognitive impairment: Challenges and opportunities. Clinical interventions in aging 2007; 2: 209-18.
3. Akimova NS, Zuev VV, Martynovich TV, et al. The relationship between the severity of chronic heart failure with the central nervous system with ischemic heart disease. Fundamental studies 2011; 11(3): 467-71. Russian (Акимова Н.С., Зуев В. В., Мартынович Т. В. и др. Взаимосвязь тяжести хронической сердечной недостаточности с состоянием центральной нервной системы при ишемической болезни сердца. Фундаментальные исследования 2011; 11(3): 467-71).
4. Dorofeeva NP, Kastanaian AA, Slik SV, et al. Polymorphisms of the renin-angiotensin system in patients with arterial hypertension and ischemic heart disease complicated with chronic heart failure. Magazine "Arterial hypertension" 2005; 11(4): 235-8. Russian (Дорофеева Н. П., Кастанаян А. А., Шлык С. В. и др. Полиморфизм генов ренинангиотензиновой системы у больных артериальной гипертензией и ишемической болезнью сердца, осложненной хронической сердечной недостаточностью. Ж Артериальная гипертензия 2005; 11(4): 235-8).
5. Spinarova L, Spinar J, Vasku A, et al. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients. Exp Mol Pathol. 2008 Jun; 84(3): 251-5. doi: 10.1016/j.yexmp.2008.03.002. Epub 2008 Mar 21.
6. BaiY Wang L, Hu S, et al. Association of angiotensin-converting enzyme I/D polymorphism with heart failure: a meta-analysis. Mol Cell Biochem 2012 Feb; 361(1-2): 297-304.
7. Akimova NS, Martynovich TV, Shvarc JG, et al. Cognitive disorders, and the status of the gray matter of the brain in CHF against the background of CAD. J Heart Failure 2011; 5(67): 282-5. Russian (Акимова Н.С., Мартынович Т. В., Шварц Ю. Г. и др. Когнитивные расстройства и состояние серого вещества головного мозга при ХСН на фоне ИБС. Ж Сердечная Недостаточность 2011; 5(67): 282-5).
8. Ostroumova OD, Desnickaja IV. The influence of Rozuvastatin on cognitive functions. Consilium medicum 2007;1(2):61-3. Russian (Остроумова О. Д., Десницкая И. В. Влияние Розувастатина на когнитивные функции. Consilium medicum 2007; 1(2): 61-3).
9. Skvorcova VI, Stahovskaja LV, Gudkova VV, et al. Chronic Ischemic disease of the brain. Consilium medicum 2006; 1(3): 92-4. Russian (Скворцова В. И., Стаховская Л.В., Гудкова В. В. и др. Хроническая ишемия головного мозга. Consilium medicum 2006; 1(3); 92-4).
10. Pasdar A, Yadegarfar G, Cumming A, et al. The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. BMC Med Genet. 2007; Published online Jun 6, 2007. doi: 10.1186/1471-2350-8-30
11. Andreassi MG, Adlerstein D, Carpeggiani C, et al. Individual and summed effects of high-risk genetic polymorphisms on recurrent cardiovascular events following ischemic heart disease. Atherosclerosis. 2012; 223(2):409-15. doi: 10.1016/j. atherosclerosis.2012.05.029. Epub 2012 Jun 6.
12. Hassan MA, Al-Attas OS, Hussain T, et al. The Q192R polymorphism of the paraoxonase 1 gene is a risk factor for coronary artery disease in Saudi subjects. Mol Cell Biochem. 2013 Aug; 380(1-2): 121-8. doi: 10.1007/s11010-013-1665-z. Epub 2013 Apr 27.
13. Scacchi R, Corbo RM, Rickards O, et al. New data on the world distribution of paraoxonase (PON1 Gln 192-Arg) gene frequencies. Hum Biol 2004 Jun; 75(3): 365-73.
14. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92: 843-9.
Review
For citations:
Martynovich T.V., Akimova N.S., Fedotov E.A., Shvarts Yu.G. GENE POLYMORPHISM IN ASSOCIATION WITH ATHEROSCLEROSIS DEVELOPMENT AND COGNITION DISORDERS IN PATIENTS WITH ISCHEMIC CHRONIC HEART FAILURE. Cardiovascular Therapy and Prevention. 2015;14(1):30-34. (In Russ.) https://doi.org/10.15829/1728-8800-2015-1-30-34